Organic compounds (class 532, subclass 1) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., oxygen, sulfur, selenium, or tellurium) or nitrogen as the only ring hetero atoms (class 540, subclass 1) > Hetero ring is six-membered consisting of one nitrogen and five carbons > Additional hetero ring containing > Patents

Resources

Home

Browse by:

Browse by Category: Main > Chemistry

Class Information
Number: 546/268.1
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., oxygen, sulfur, selenium, or tellurium) or nitrogen as the only ring hetero atoms (class 540, subclass 1) > Hetero ring is six-membered consisting of one nitrogen and five carbons > Additional hetero ring containing
Description: Compounds which contain an additional hetero ring.

Sub-classes under this class:

Class Number	Class Name	Patents
546/268.4	The additional hetero ring is five-membered having two or more ring hetero atoms of which at least one is nitrogen	421
546/276.4	The additional hetero ring is five-membered consisting of one nitrogen and four carbons	724
546/279.7	Ring sulfur in the additional hetero ring	77
546/281.7	Ring oxygen in the additional hetero ring	241

Patents under this class:

1 2 3 4 5 6 7 8 9

Patent Number	Title Of Patent	Date Issued
7622589	Substituted sulfonylaminoarylmethyl cyclopropanecarboxamide as VR1 receptor antagonists	Nov. 24, 2009
7619090	Monocyclopentadienyl complexes comprising a condensed heterocycle	Nov. 17, 2009
7615570	Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof	Nov. 10, 2009
7601716	Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors	Oct. 13, 2009
7598236	Diazabicyclic central nervous system active agents	Oct. 6, 2009
7598423	Potentiators of glutamate receptors	Oct. 6, 2009
7595321	Compounds having selective inhibiting effect at GSK3	Sep. 29, 2009
7595343	Inhibitors of histone deacetylase	Sep. 29, 2009
7595334	Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors	Sep. 29, 2009
7592337	Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5	Sep. 22, 2009
7582366	Difluoropyridine-based compound and organic electroluminescent device using the same	Sep. 1, 2009
7582657	Vanilloid receptor ligands and their use in treatments	Sep. 1, 2009
7579347	Vanilloid receptor ligands and their use in treatments	Aug. 25, 2009
7576098	Heterocyclic compounds as inhibitors of factor VIIa	Aug. 18, 2009
7572816	Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders	Aug. 11, 2009
7572792	Azetidine glycine transporter inhibitors	Aug. 11, 2009
7569694	Coumarin compound, material for light emitting device and organic electroluminescent device	Aug. 4, 2009
7560563	Process for producing 2-substituted pyridine derivative	Jul. 14, 2009
7547711	Heterocyclic inhibitors of kinases	Jun. 16, 2009
7547782	Met kinase inhibitors	Jun. 16, 2009
7544704	Aryl-4-ethynyl-isoxazole derivatives	Jun. 9, 2009
7538138	Amines as histamine-3 receptor ligands and their therapeutic applications	May. 26, 2009
7524874	Vanilloid receptor ligands and their use in treatments	Apr. 28, 2009
7524864	Methods of treating sleep disorders	Apr. 28, 2009
7524870	Biaryloxymethylarenecarboxylic acids as glycogen synthase activators	Apr. 28, 2009
7517893	Bichalcophenes and their prodrugs as antiprotozoal agents	Apr. 14, 2009
7511042	Triazole compounds	Mar. 31, 2009
7501445	Imidazolidinone compounds	Mar. 10, 2009
7498354	Pyrrolo[2,3-D]imidazoles for the treatment of hyperproliferative disorders	Mar. 3, 2009
7498353	Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses	Mar. 3, 2009
7494997	Amide derivative	Feb. 24, 2009
7491724	Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases	Feb. 17, 2009
7488824	Process for the production of substituted nicotinic acid esters	Feb. 10, 2009
7488742	Thrombin receptor antagonists	Feb. 10, 2009
7485653	1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease	Feb. 3, 2009
7456197	Pyridinium cationic lipids as gene transfer agents	Nov. 25, 2008
7449489	Indolylalkylamino-methylidenecarbamate derivatives useful as GnRH antagonists	Nov. 11, 2008
7446119	Miticidal triazolidine derivatives	Nov. 4, 2008
7442716	2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors	Oct. 28, 2008
7442701	Amino-heterocycles as VR-1 antagonists for treating pain	Oct. 28, 2008
7442713	2-thio-substituted imidazole derivatives and their use in pharmaceutics	Oct. 28, 2008
7442799	Preparation and use of 2-substituted-5-oxo-3-pyrazolidinecarboxylates	Oct. 28, 2008
7439260	7-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitors	Oct. 21, 2008
7435815	Sulfonylamino-acetic acid derivatives	Oct. 14, 2008
7432289	5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors	Oct. 7, 2008
7432286	Pharmaceutically active sulfonyl hydrazide derivatives	Oct. 7, 2008
7429604	Six-membered heterocycles useful as serine protease inhibitors	Sep. 30, 2008
7423061	Substitute thiophenes and uses thereof	Sep. 9, 2008
7423051	2,6-diaminopyridine derivatives	Sep. 9, 2008
7414064	4-(3,3-dihalo-allyloxy) phenoxy alkyl derivatives	Aug. 19, 2008